{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:11:50Z","timestamp":1775801510832,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":730,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.jvs.2012.05.064","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T06:46:18Z","timestamp":1347086778000},"page":"1622-1628.e5","source":"Crossref","is-referenced-by-count":24,"title":["Effect on walking distance and atherosclerosis progression of a nitric oxide-donating agent in intermittent claudication"],"prefix":"10.1016","volume":"56","clinical-trial-number":[{"clinical-trial-number":"nct01256775","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Paolo","family":"Gresele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rino","family":"Migliacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erminio","family":"Bonizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Minuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2012.05.064_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJMcp064483","article-title":"Clinical practice","volume":"356","author":"White","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2012.05.064_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2012.05.064_bib3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0735-1097(03)00994-X","article-title":"The clinical implications of endothelial dysfunction","volume":"42","author":"Widlansky","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2012.05.064_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2217\/bmm.10.61","article-title":"Endothelial function as a functional expression of cardiovascular risk factors","volume":"4","author":"Reriani","year":"2010","journal-title":"Biomark Med"},{"key":"10.1016\/j.jvs.2012.05.064_bib5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2008.01.014","article-title":"In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction","volume":"201","author":"Brevetti","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2012.05.064_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0021-9150(02)00235-6","article-title":"Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication","volume":"165","author":"Silvestro","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2012.05.064_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1160\/TH06-10-0555","article-title":"Prevention by NCX 4016, a nitric oxide-donating aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication","volume":"97","author":"Gresele","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2012.05.064_bib8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2012.05.064_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib10","doi-asserted-by":"crossref","first-page":"742e","DOI":"10.1016\/j.ehj.2004.02.012","article-title":"Statin therapy improves cardiovascular outcome of patients with peripheral artery disease","volume":"25","author":"Schillinger","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2012.05.064_bib11","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.atherosclerosis.2008.08.022","article-title":"The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis","volume":"203","author":"Blum","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jvs.2012.05.064_bib12","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0735-1097(98)00375-1","article-title":"Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease","volume":"32","author":"B\u00f6ger","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2012.05.064_bib13","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0735-1097(96)00337-3","article-title":"Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits","volume":"28","author":"Wang","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2012.05.064_bib14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIRCULATIONAHA.106.683656","article-title":"l-arginine supplementation in peripheral arterial disease: no benefit and possible harm","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib15","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1161\/01.CIR.0000018745.11739.9B","article-title":"S-nitroso human serum albumin treatment reduces ischemia\/reperfusion injury in skeletal muscle via nitric oxide release","volume":"105","author":"Hallstr\u00f6m","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/ATVBAHA.107.149278","article-title":"Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion","volume":"27","author":"Dragoni","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2012.05.064_bib17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0741-5214(98)70067-9","article-title":"A randomized, double-blind, placebo-controlled, crossover study to assess the immediate effect of sublingual glyceryl trinitrate on the ankle brachial pressure index, claudication, and maximum walking distance of patients with intermittent claudication","volume":"28","author":"Walker","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2012.05.064_bib18","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1016\/S0002-8703(03)00391-0","article-title":"Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease","volume":"146","author":"De Berrazueta","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2012.05.064_bib19","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1527-3466.2006.00148.x","article-title":"Pharmacologic profile and therapeutic potential of NCX 4016, a nitric oxide-releasing aspirin, for cardiovascular disorders","volume":"24","author":"Gresele","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.jvs.2012.05.064_bib20","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1073\/pnas.041602898","article-title":"Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice","volume":"98","author":"Napoli","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2012.05.064_bib21","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.2337\/dc09-2013","article-title":"Hyperglycemia-induced platelet activation in type 2 diabetes is resistant to aspirin but not to a nitric oxide-donating agent","volume":"33","author":"Gresele","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvs.2012.05.064_bib22","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1152\/ajpendo.00622.2007","article-title":"The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes","volume":"295","author":"Kaddai","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jvs.2012.05.064_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/eurheartj\/ehn070","article-title":"Ultrasound imaging techniques for the evaluation of cardiovascular therapies","volume":"29","author":"Kastelein","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2012.05.064_bib24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1055\/s-0037-1616048","article-title":"Treatment of intermittent claudication with mesoglycan\u2013a placebo-controlled, double-blind study","volume":"86","author":"Nenci","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2012.05.064_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/1358863X10361545","article-title":"A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication","volume":"15","author":"Pande","year":"2010","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2012.05.064_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1358836X0000500204","volume":"5","author":"Gresele","year":"2000","journal-title":"Vasc Med"},{"key":"10.1016\/j.jvs.2012.05.064_bib27","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1152\/japplphysiol.00515.2003","article-title":"l-arginine protects from ischemia-reperfusion-induced endothelial dysfunction in humans in vivo","volume":"95","author":"Pernow","year":"2003","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jvs.2012.05.064_bib28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2796.2009.02073.x","article-title":"Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study","volume":"265","author":"Bots","year":"2009","journal-title":"J Intern Med"},{"key":"10.1016\/j.jvs.2012.05.064_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/01.CIR.103.7.919","article-title":"Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE)","volume":"103","author":"Lonn","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2796.2007.01775.x","article-title":"Irbesartan reduces common carotid artery intima-media thickness in hypertensive patients when compared with atenolol: the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study","volume":"261","author":"M\u00f6rtsell","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.jvs.2012.05.064_bib32","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jvs.2008.02.062","article-title":"Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions","volume":"48","author":"Iida","year":"2008","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2012.05.064_bib33","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1161\/CIRCULATIONAHA.109.892414","article-title":"The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the diabetic atherosclerosis prevention by cilostazol (DAPC) study: a randomized trial","volume":"121","author":"Katakami","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib34","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1161\/01.CIR.0000165072.01672.21","article-title":"Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study","volume":"111","author":"Langenfeld","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib35","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/eurheartj\/ehl136","article-title":"Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study","volume":"27","author":"Dijk","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2012.05.064_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/01.LAB.0000018828.61722.BD","article-title":"Nitric oxide-releasing aspirin decreases vascular injury by reducing inflammation and promoting apoptosis","volume":"82","author":"Yu","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.jvs.2012.05.064_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH04-07-0464","article-title":"Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice","volume":"93","author":"Momi","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jvs.2012.05.064_bib38","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1161\/01.CIR.0000147540.88559.00","article-title":"Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study","volume":"110","author":"Juonala","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2012.05.064_bib39","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/archinte.159.17.2041","article-title":"A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial","volume":"159","author":"Beebe","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jvs.2012.05.064_bib40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejvs.2009.09.027","article-title":"A systematic review of implementation of established recommended secondary prevention measures in patients with PAOD","volume":"39","author":"Flu","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2012.05.064_bib41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004\u20132006)","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jvs.2012.05.064_bib42","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/01.ATV.0000144030.39087.3b","article-title":"Nitric oxide-releasing aspirin derivative, NCX 4016, promotes reparative angiogenesis and prevents apoptosis and oxidative stress in a mouse model of peripheral ischemia","volume":"24","author":"Emanueli","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2012.05.064_fr1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000097034","article-title":"Mannheim carotid intima-media thickness consensus (2004\u20132006)","volume":"23","author":"Touboul","year":"2007","journal-title":"Cerebrovasc Dis"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521412012505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521412012505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T16:16:14Z","timestamp":1562170574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521412012505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0741521412012505"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2012.05.064","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}